Zydus Lifesciences Ltd receives 6 observations from USFDA for API site at Changodar

Zydus Lifesciences Ltd has announced that the USFDA conducted an inspection at the API site situated at Changodar, Ahmedabad. This PAI-cum-GMP USFDA inspection was conducted from December 14 to December 22, 2023. The inspection closed with 6 observations. There were no Data Integrity related observations. There are no repeat observations from the previous inspection.

There are 4 DMFs of this site under approval with the USFDA. The Company will closely work with the USFDA to address the observations.

Shares of Zydus Lifesciences Limited was last trading in BSE at Rs. 679.95 as compared to the previous close of Rs. 670.90. The total number of shares traded during the day was 29071 in over 1267 trades.

The stock hit an intraday high of Rs. 689.15 and intraday low of 673.65. The net turnover during the day was Rs. 19817821.00.

Source : Equity Bulls

Keywords

ZydusLifesciences INE010B01027 USFDA 6Observations APISite Changodar